Skip to main content

ChronoScale Corporation

corporate_fare Company Profile

ChronoScale Corporation

EKSO·NASDAQ·Technology

Ekso Bionics Holdings, Inc. designs, develops, distributes, and commercializes exoskeleton products across the Americas, Europe, the Middle East, Africa, the Asia Pacific, and internationally. The company offers several key products, including EksoNR, a wearable robotic exoskeleton; Ekso Indego Therapy, a powered exoskeleton; Ekso Indego Personal, a powered lower limb orthosis; and Ekso EVO, a wearable upper body exoskeleton. Additionally, Ekso Bionics Holdings, Inc. is developing Ekso Nomad, a power Knee Ankle Foot Orthosis (KAFO), and the MediTouch BalanceTutor rehabilitation system, which is a multidirectional perturbation treadmill. The company was founded in 2005 and is based in San Rafael, California.

ChronoScale Corporation (NASDAQ:EKSO) is a publicly traded company in the Technology sector. Wiseek monitors EKSO SEC EDGAR filings and licensed market news in real time, scoring each submission for market-moving significance on a 1–10 scale. Items rated 7 or higher generate instant alerts.

Recent high-impact activity:

  • ChronoScale Corporation Finalizes Business Combination, Secures $15.75M PIPE, and Reconstitutes Board
  • Ekso Bionics Finalizes Business Combination, Secures $15.75M PIPE, Rebrands to ChronoScale
  • EKSO Q1 Revenue Plunges 37% to $2.14M, EPS at $(2.04) Amid Device Sales Decline
  • Definitive Statement Filed for Reverse Merger, 97% Dilution for Existing Shareholders
  • Ekso Bionics Details 97% Dilutive Reverse Merger into AI Cloud Business, $15M Financing, and New Equity Plan
Browse all tickers starting with E →
$12 +0.20% today
Market cap
$42.05M
Volume
100.6K (1.8× avg)
3-mo avg 57.2K
Live data · 2026-06-14 03:53 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed EKSO - Latest Insights

EKSO
May 05, 2026, 5:10 PM EDT
Filing Type: 8-K/A
Importance Score:
10
ChronoScale Corporation Finalizes Business Combination, Secures $15.75M PIPE, and Reconstitutes Board
Price at Filing: $12.00
Real-time Price: $12.00 info
Change: $0 (0%) info
Market Cap: $42.048M info
Sentiment: Negative
View Wiseek Article
EKSO
May 04, 2026, 4:01 PM EDT
Filing Type: 8-K
Importance Score:
9
Ekso Bionics Finalizes Business Combination, Secures $15.75M PIPE, Rebrands to ChronoScale
Price at Filing: $11.95
Real-time Price: $12.00 info
Change: +$0.050 (+0.42%) info
Market Cap: $42.048M info
Sentiment: Neutral
View Wiseek Article
EKSO
Apr 28, 2026, 5:21 PM EDT
Source: Wiseek News
Importance Score:
8
EKSO Q1 Revenue Plunges 37% to $2.14M, EPS at $(2.04) Amid Device Sales Decline
Price at Filing: $11.21
Real-time Price: $12.00 info
Change: +$0.790 (+7%) info
Market Cap: $42.048M info
Sentiment: Negative
View Wiseek Article
EKSO
Apr 03, 2026, 5:05 PM EDT
Filing Type: DEF 14C
Importance Score:
9
Definitive Statement Filed for Reverse Merger, 97% Dilution for Existing Shareholders
Price at Filing: $9.27
Real-time Price: $12.00 info
Change: +$2.73 (+29%) info
Market Cap: $42.048M info
Sentiment: Negative
View Wiseek Article
EKSO
Apr 02, 2026, 8:08 PM EDT
Filing Type: PRER14C
Importance Score:
9
Ekso Bionics Details 97% Dilutive Reverse Merger into AI Cloud Business, $15M Financing, and New Equity Plan
Price at Filing: $9.27
Real-time Price: $12.00 info
Change: +$2.73 (+29%) info
Market Cap: $42.048M info
Sentiment: Negative
View Wiseek Article
EKSO
Mar 30, 2026, 7:38 PM EDT
Filing Type: PRER14C
Importance Score:
9
Ekso Bionics Details 97% Dilutive Reverse Merger, Pivots to AI Cloud as "ChronoScale"
Price at Filing: $10.23
Real-time Price: $12.00 info
Change: +$1.77 (+17%) info
Market Cap: $42.048M info
Sentiment: Negative
View Wiseek Article
EKSO
Mar 20, 2026, 5:13 PM EDT
Filing Type: PREM14C
Importance Score:
9
Ekso Bionics to Become ChronoScale Corp. via Reverse Merger, Existing Shareholders Face 97% Dilution
Price at Filing: $10.69
Real-time Price: $12.00 info
Change: +$1.31 (+12%) info
Market Cap: $42.048M info
Sentiment: Negative
View Wiseek Article
EKSO
Feb 23, 2026, 4:06 PM EST
Filing Type: 10-K
Importance Score:
10
Annual Report Confirms Reverse Merger with 97% Dilution and Going Concern Warning
Price at Filing: $10.64
Real-time Price: $12.00 info
Change: +$1.36 (+13%) info
Market Cap: $42.048M info
Sentiment: Negative
View Wiseek Article
EKSO
Feb 20, 2026, 4:57 PM EST
Filing Type: 4
Importance Score:
7
10% Owner Daniel Asher Buys $191K in Ekso Bionics Shares Following Reverse Merger News
Price at Filing: $11.18
Real-time Price: $12.00 info
Change: +$0.8171 (+7%) info
Market Cap: $42.048M info
Sentiment: Positive
View Wiseek Article
EKSO
Feb 17, 2026, 3:42 PM EST
Filing Type: 4
Importance Score:
8
10% Owner Daniel Asher Buys Nearly $1M in EKSO Shares Ahead of Reverse Merger News
Price at Filing: $10.66
Real-time Price: $12.00 info
Change: +$1.34 (+13%) info
Market Cap: $42.048M info
Sentiment: Positive
View Wiseek Article
EKSO
Feb 17, 2026, 6:07 AM EST
Filing Type: DEFA14A
Importance Score:
10
Ekso Bionics Announces Transformational Acquisition, 38x Dilution, and Change of Control to Applied Digital Cloud
Price at Filing: $9.87
Real-time Price: $12.00 info
Change: +$2.13 (+22%) info
Market Cap: $42.048M info
Sentiment: Negative
View Wiseek Article
EKSO
Feb 17, 2026, 6:06 AM EST
Filing Type: 8-K
Importance Score:
10
Ekso Bionics Announces Transformative Reverse Merger with Applied Digital Cloud, Leading to Extreme Shareholder Dilution and Control Shift
Price at Filing: $9.87
Real-time Price: $12.00 info
Change: +$2.13 (+22%) info
Market Cap: $42.048M info
Sentiment: Negative
View Wiseek Article
EKSO
Jan 22, 2026, 4:57 PM EST
Filing Type: 8-K
Importance Score:
7
Ekso Bionics Raises $5.3M via Convertible Preferred Stock Offering
Price at Filing: $7.90
Real-time Price: $12.00 info
Change: +$4.10 (+52%) info
Market Cap: $42.048M info
Sentiment: Neutral
View Wiseek Article